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The study aims to determine whether type and density of tumour-infiltrating lymphocytes (TILs) can predict the clinical course in
gastric cancer. Gastric carcinomas (n¼220) were immunostained for CD3, CD8, CD20, and CD45RO and evaluated for
clinicopathologic characteristics. Number of TILs that immunostained positively for each marker were counted using NIH ImageJ
software. Tumours were grouped into low- and high-density groups for each marker (CD3, CD8, CD45RO). The densities of
CD3
þ, CD8
þ, and CD45RO
þ TILs were found to be independent predictors of lymph node metastasis by multivariate analysis
with odds ratios (95% CI) of 0.425 (0.204–0.885), 0.325 (0.150–0.707), and 0.402 (0.190–0.850), respectively. Kaplan–Meier
survival analysis revealed that patients in the high-density groups for CD3, CD8, and C45RO had a significantly longer survival time
than the patients in the corresponding low-density groups, respectively. In multivariate survival analysis, the densities of CD3
þ,
CD8
þ, and CD45RO
þ TILs remained independent prognostic factors with hazard ratios (95% CI) of 0.549 (0.317–0.951), 0.574
(0.347–0.949), and 0.507 (0.298–0.862), respectively. In conclusion, density of TILs was found to be independently predictive of
regional lymph node metastasis and patient survival in gastric cancer.
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Despite a decreasing trend in its incidence, gastric cancer remains
one of the most frequent causes of cancer-related death worldwide;
more than 930000 new cases are diagnosed and 700000 deaths
occur each year (Parkin et al, 2005). At present, surgical resection
is considered the most reasonable procedure (Engstrom et al, 1985;
Coombes et al, 1990), and tumour-node-metastasis (TNM) stage
(by UICC/AJCC) assessed after resection is viewed as the
prognostic factor that is most strongly associated with patient
survival. However, it is not rare that gastric cancer patients with
the same TNM stage pursue different clinical courses. Histopatho-
logic classifications including WHO classification (Fenoglio-
Preiser et al, 2000), Lauren’s classification (Lauren, 1965), Ming’s
classification (Ming, 1977), and Goseki classification (Goseki et al,
1992) and molecular classifications (Hippo et al, 2002; Chen et al,
2005) have also been applied for the prediction of patient survival,
but their prognostic accuracies are controversial (Lewin and
Appleman, 1996; Fenoglio-Preiser et al, 2000). In addition, many
attempts have been made to link molecular events in cancer cells
with patient outcome, but none of these have been accepted to
be clinically meaningful. In consequence, new prognostic
determinants in conjunction with the TNM stage are required to
predict patients’ clinical course more reliably and precisely.
As the cancer immunosurveillance hypothesis was first pro-
posed, the concept that the immune system can recognise and
eliminate tumour cells has been energetically debated. Many
experimental rodent studies on transgenic and knockout mice, and
on monoclonal antibodies specific for distinct immunologic
components have provided substantial evidence for the existence
of cancer immunosurveillance, and in particular, have shown that
the immune system indeed functions to protect murine hosts
against development of both chemically induced and spontaneous
tumours (Dunn et al, 2004). Moreover, in humans, epidemiologic
data indicate that immunocompromised patients have a higher
probability of developing cancers of both viral and non-viral
origin, which supports the cancer immunosurveillance concept
(Dunn et al, 2004). In addition, an accumulating evidence shows a
positive correlation between the presence of lymphocytes in
tumour tissue and increased patient survival.
Recent studies have shown that several types of tumour-
infiltrating lymphocytes (TIL) are associated with better disease
outcome for various human cancers, including melanoma
(Clemente et al, 1996; Taylor et al, 2007) and colorectal (Pages
et al, 2005; Galon et al, 2006), ovarian (Zhang et al, 2003), cervical
(Piersma et al, 2007), hepatocellular (Gao et al, 2007), and
urothelial (Sharma et al, 2007) carcinoma. These reports
demonstrate that high numbers of CD3
þ, CD8
þ, or CD45RO
þ
T cells in tumour tissue are significantly correlated with lower
frequencies of lymph node metastasis or disease recurrence, or
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slonger patient survival. Moreover, Galon et al (2006) advocated
that the type, density, and location of immune cells in colorectal
cancer have prognostic values that are superior to and indepen-
dent of those of the TNM classification . However, the effect of
TILs on the clinical course of gastric cancer patients is largely
unknown.
The aim of this study was to assess the prognostic role of TILs in
gastric cancer. Here, we determined whether type and density of
TILs can predict the regional lymph node metastasis and patient
survival in gastric cancer.
MATERIALS AND METHODS
Patients and specimens
The files of 274 surgically resected consecutive gastric carcinoma
cases examined at the Department of Pathology, Seoul National
University Hospital between January and June 1995 were obtained
to quantify TILs by immunohistochemistry using a tissue array
method. Cases with cancer confined to mucosa were excluded
because they have an excellent prognosis regardless of TIL status.
Finally 220 tumour tissue samples were included in the analysis.
Age, sex, histologic type (according to Lauren and WHO
classifications), lymphatic invasion, and pTNM (pathologic
TNM) stage were evaluated by reviewing medical records or the
glass slides. Patient clinical outcomes were followed from the date
of surgery until either the date of death or 31 December 2003,
which resulted in a follow-up period that ranged from 1 to 108
months (mean, 64.4 months). The data of patients lost to follow-up
and of those who died from a cause other than gastric cancer were
regarded as censored during the survival analysis. No patient had
received preoperative chemotherapy, and patients with stage II, III,
and IV had received postoperative chemotherapy using fluoro-
uracil (5-FU) -based regimen (5-FU alone, 5-FU plus mitomycin C,
or 5-FU plus cisplatin). No patient had received pre or post-
operative radiotherapy. This study was approved by the Institu-
tional Review Board for Human Subject Research at Seoul National
University Hospital.
Tissue array method
Core tissue biopsies (2mm in diameter) were taken from
individual paraffin-embedded gastric carcinomas (donor blocks)
and re-arranged in a new recipient paraffin block (tissue array
block) using a trephine apparatus (Superbiochips Laboratories,
Seoul, Korea). Six array blocks containing a total of 274 cases were
prepared. As it has been shown that excellent staining result
agreements are obtained for different intratumoral areas of gastric
carcinomas (Lee et al, 2001), a core was sampled from each of the
cases. Each paraffin block contained internal controls consisting of
non-neoplastic gastric mucosa from the body, antrum, and
intestinal metaplasia. Sections (4mm) were taken from each tissue
array block, deparaffinised, and dehydrated.
Immunohistochemistry
Formalin-fixed and paraffin-embedded sections were dewaxed in
xylene, rehydrated through graded alcohol, and placed in an
endogenous peroxide block for 15min. Antigen retrieval was done
using a microwave in 10mM citrate buffer or using an autoclave in
Borg solution (Biocare Medical, Walnut Creek, CA, USA). Non-
specific staining was blocked by treating sections with 1% horse
serum in Tris-buffered saline (pH 6.0) for 3min. Anti-CD3 (total
T-cell marker; microwave; 1:100; rabbit polyclonal; DAKO,
Glostrup, Denmark), -CD8 (cytotoxic T-cell marker; autoclave
in Borg solution; 1:100; Rabbit monoclonal, SP16; Neomarkers,
Fremont, CA, USA), -CD20 (total B cell marker; microwave; 1:300;
Mouse monoclonal, L26; DAKO), and -CD45RO (memory
T-cell marker; microwave; 1:100; Mouse monoclonal, OPD4;
Neomarkers) antibodies were then applied, and antibody binding
was detected using an avidin–biotin–peroxidase complex
(Universal Elite ABC Kit; Vectastain, Burlingame, CA, USA) for
10min. Diaminobenzidine tetrahydrochloride solution (Kit HK153-
5K; Biogenex, San Ramon, CA, USA) was then used as a chromogen.
Quantitative analysis of TILs
Immunostained slides were scanned with a digital virtual
microscope (dotSlide, Olympus, Hamburg, Germany), and a
portion (area of 0.44mm
2 of tumour centre) of the virtual images
was captured using an image viewer programme (OlyVIA,
downloaded from http://www.olysia.co.kr/olyvia2992.zip) per case.
The captured images were 1263 932 pixel in size and had a
resolution of 1.633 pixelmm
 1 at a magnification of  100.
Numbers of positively immunostained cells per in the 0.44mm
2
target areas were counted using NIH imageJ software with a Java-
based colour deconvolution plugin (http://rsb.info.nih.gov/ij).
Statistical analysis
Comparisons between groups were performed using the Pearson’s
w
2 test or Fisher’s exact (2-sided) test. Multivariate logistic
regression was used to identify clinical and pathologic features
predictive of regional lymph node metastases. Survival curves were
estimated using the Kaplan–Meier product-limit method, and the
significances of differences between survival curves were deter-
mined using the log-rank test. Multivariate comparisons of
survival distributions were made using Cox proportional hazards
models. All statistical analyses were conducted using SPSS 15.0
(SPSS, Chicago, IL, USA), and P-values of p0.05 were considered
statistically significant.
Two-fold cross-validation approach
To dichotomise prognostic variables, CD3, CD8, and CD45RO, a
two-fold cross-validation methodology and a minimum P-value
approach (Mazumdar et al, 2003) were used. The dataset was
randomly divided into two subsets. The inner 70% of the
distribution from a marker was chosen as a selection interval of
an optimal cutoff value. Stratified univariate and multivariate tests
(logistic regression and Cox proportional hazards model) were
performed for significance of prognostic variables.
RESULTS
Density of TILs
Tumour-infiltrating lymphocytes were detected within cancer
epithelium or in stroma except for CD20
þ TILs, which were
mostly present in stroma (Figure 1). Mean numbers of CD3
þ,
CD8
þ, CD45RO
þ, and CD20
þ TILs per area of 0.44mm
2 were
353.87±381.55, 191.72±265.69, 76.13±138.30, and 89.42±152.45,
respectively. Numbers of CD3
þ, CD8
þ, and CD45RO
þ TILs were
correlated with each other (range of correlation coefficients,
0.739–0.868; Po0.001), and numbers of CD20
þ TIL were
positively correlated with those of other TIL subtypes, but
correlation coefficients were relatively low (range, 0.527–0.641;
Po0.001). First, using mean number, all cases were classified into
low- and high-density groups for each marker, that is, CD3L, CD8L,
and CD45ROL (low-density groups) and CD3H, CD8H, and
CD45ROH (high-density groups) (Table 1). Also, each 75th
percentile in the distributions of the TIL numbers in ascending
order were determined as cutoffs (75th percentile cutoffs) for
dichotomisation of the variables, that is, 75th percentile or a
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spercentile less than 75 were considered as low-density groups and
a percentile greater than 75 as high-density groups for each
marker. Each 75th percentile was 452, 191, and 92 per area of
0.44mm
2, for CD3
þ, CD8
þ, and CD45RO
þ TILs, respectively. We
also grouped cases using combined variables, that is, as high or
low for CD3þCD8, CD3þCD45RO, CD8þCD45RO, and
CD3þCD8þCD45RO (refer to Table 1 for a complete list).
We then compared groups dichotomised about means and
about 75th percentile cutoffs. Because comparisons of the high-
and low-density groups of CD20
þ, TIL using various cutoffs failed
to show any significant difference in terms of clinicopathologic
characteristics or survival, no detailed data on CD20
þ TIL is
presented.
Correlation between TIL density and clinicopathologic
characteristics
In a total of 220 gastric cancer patients, median age was 57 years
(range, 18–80 years), and 70.9%. were male. The clinical and
pathological characteristics of the cases grouped by TIL density
with mean value cutoffs are summarised in Table 2. TIL density
showed no correlation with either tumour invasion depth or the
presence of lymphatic invasion, but it was found to be significantly
associated with the presence of regional lymph node metastasis;
CD3H, CD8H, and CD45ROH groups showed a lower frequency of
lymph node metastasis than the corresponding low-density
groups. Considering this observation, we assumed that TIL density
would predict lymph node metastasis in gastric cancer.
TIL as a predictor of regional lymph node metastasis
According to univariate logistic regression model, an advanced T
stage, the presence of lymphatic invasion, and low densities of
CD3
þ, CD8
þ, or CD45RO
þ TILs were significantly associated
with presence of regional lymph node metastasis regardless of the
grouping method (mean value cutoff or 75th percentile cutoff).
Low-density groups by combination of variables also showed
significant relationships with the presence of lymph node
metastasis. Multivariate logistic regression analysis, after adjusting
for tumour invasion (T stage) and lymphatic invasion, demon-
strated that densities of CD3
þ, CD8
þ, and CD45RO
þ TILs
were independent predictors of lymph node metastasis. As
expected, combined analysis of variables showed similar results
(Tables 3 and 4).
TIL as a predictor of patient survival
Significant advantages for overall survival were found for the
CD3H, CD8H, and CD45ROH groups and for the high-density
groups of combined TIL variables (refer to Table 1) according to
75th percentile cutoffs by Kaplan–Meier survival analysis
(Figure 2). The analysis with variables according to mean value
cutoffs showed similar results (data not shown). CD3H, CD8H, and
CD45ROH groups had mean survival times of 85.1±5.2, 81.0±5.3,
and 83.1±5.3 months, respectively, as compared with only
63.0±3.5, 64.3±3.5, and 63.7±3.5 months in the corresponding
low-density groups. Thus, the density of various TILs seems to be
useful for defining a subgroup with unfavourable prognosis in
gastric cancer.
Univariate Cox regression analysis for the prediction of overall
survival also confirmed that the CD3H, CD8H, and CD45ROH
groups and the high-density groups of combined TIL variables had
better survival than the corresponding low-density groups
regardless of the grouping method (mean value cutoff or 75th
percentile cutoff). In addition, densities of CD3
þ, CD8
þ and
CD45RO
þ TILs and the combined TIL densities remained
significant predictors of overall survival by multivariate Cox
proportional hazard analysis, even after controlling for T stage,
histologic classification (WHO), presence of lymph node
metastasis, and presence of lymphatic invasion, which were all
found to be of prognostic significance by univariate analysis
(Tables 5 and 6).
Two-fold cross-validation approach
For further validation of our results, we performed a two-fold
cross-validation approach. In analyses using this approach,
univariate and multivariate logistic regression analyses confirmed
that densities of CD3
þ, CD8
þ, and CD45RO
þ TILs were
independent predictors of regional lymph node metastasis
(Table 7). In univariate Cox regression analysis, CD3H, CD8H,
and CD45ROH groups were proved to have longer survival time
than the corresponding low-density groups (Table 8). In multi-
variate Cox regression analysis, CD45RO
þ TIL density remained a
statistically significant predictor of overall survival, and CD8
þ TIL
density was associated with overall survival marginally, but CD3
þ
TlL density did not remain a significant predictor (Table 8).
Table 1 Classification of the gastric cancers according to TIL density
Variables
Mean value
cutoff
(cases, N)
75th percentile
cutoff
(cases, N)
CD3L/CD3H 142/78 165/55
CD8L/CD8H 164/56 164/56
CD45ROL/CD45ROH 155/65 165/55
Combination of variables
CD3LCD8 L/CD3CD8Het/CD3HCD8H 135/36/49 150/29/41
CD3LCD45ROL/CD3CD45ROHet/
CD3HCD45ROH
131/35/54 148/34/38
CD8LCD45ROL/CD8CD45ROHet/
CD8HCD45ROH
140/39/41 146/37/37
CD3LCD8LCD45ROL/
CD3CD8CD45ROHet/
CD3HCD8HCD45ROH
125/55/40 138/50/32
H¼high density group; Het¼mixture of low and high density group for different
markers; L¼low density group.
A
CD
B
Figure 1 Types of tumour-infiltrating lymphocytes. CD3 (A), CD8 (B),
CD45RO (C), and CD20 (D) expressing cells were detected immuno-
histochemically. They are tumour-infiltrating total T cells, cytotoxic T cells,
memory T cells, and B cells, respectively (original magnification,  100).
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sDISCUSSION
The present study demonstrates that the type and density of TILs
correlate with the clinical outcome after gastrectomy in gastric
cancer. TIL was found to be an independent predictor of lymph
node metastasis and an independent prognostic factor of patients’
overall survival by multivariate analyses. In addition, we evaluated
an effect of TIL density on survival at each stage of TNM
classification. Overall survival of patients with a high TIL density
tended to be longer than that of patients with a low TIL density
within the same TNM stage, although differences were not
statistically significant due to small numbers of cases enrolled in
Table 3 Univariate and multivariate logistic regression models for
predictors of regional lymph node metastasis (results from mean value
cutoffs)
Univariate analysis Multivariate analysis
a
Variables OR 95% CI P-value OR 95% CI P-value
CD3
b 0.308 0.164–0.580 o0.001 0.350 0.175–0.701 0.003
CD8
b 0.436 0.225–0.843 0.014 0.325 0.150–0.707 0.005
CD45RO
b 0.310 0.163–0.589 o0.001 0.302 0.147–0.622 0.001
CD3CD8
c 0.307 0.148–0.640 0.002 0.277 0.122–0.632 0.002
CD3CD45RO
c 0.234 0.116–0.473 o0.001 0.236 0.107–0.523 o0.001
CD8CD45RO
c 0.292 0.136–0.625 0.002 0.260 0.111–0.608 0.002
CD3CD8
CD45RO
d
0.258 0.117–0.567 0.001 0.257 0.108–0.614 0.028
CI¼confidence interval; OR¼odds ratio. The results were according to the density
groups of TIL with mean value cutoffs. Univariate and multivariate logistic regression
models were used as statistical methods.
aTumour invasion (T stage) and presence of
lymphatic invasion were adopted as covariates in each multivariate analysis.
bhigh vs
low.
chigh/high vs low/low.
dhigh/high/high vs low/low/low.
Table 2 Correlation between TIL density and clinicopathologic characteristics in the 220 gastric cancers
CD3
+ TIL CD8
+ TIL CD45RO
+ TIL
Characteristics Low High P-value* Low High P-value* Low High P-value*
Age (years) 0.026 0.250 0.167
o66 108 69 129 48 121 56
X66 34 9 35 8 34 9
Gender 0.023 0.109 0.315
Male 108 48 121 35 113 43
Female 34 30 43 21 42 22
WHO classification 0.148 0.008 0.118
WD 9 3 11 1 9 3
MD 50 23 58 15 53 20
PD 58 44 65 37 65 37
Mucinous 9 1 9 1 10 0
SRC 16 7 21 2 18 5
Lymphatic invasion 0.143 0.590 0.446
Absent 88 56 109 35 99 45
Present 54 22 55 21 56 20
Tumour stage 0.095 0.924 0.366
T1/2 98 62 119 41 110 50
T3/4 44 16 45 15 45 15
LN metastasis o0.001 0.012 o0.001
Absent 24 31 34 21 28 27
Present 118 47 130 35 127 38
TNM stage 0.001 0.250 0.018
I 3 23 5 4 42 3 3 82 9
II 32 21 41 12 38 15
III 44 11 44 11 45 10
IV 34 11 35 10 34 11
LN¼lymph node; MD¼moderately differentiated tubular adenocarcinoma; Mucinous¼mucinous adenocarcinoma; PD¼poorly differentiated tubular adenocarcinoma;
SRC¼signet-ring cell carcinoma; WD¼well differentiated tubular adenocarcinoma. The results were according to the density groups of TIL with mean value cutoffs. *w
2 test
was used as a statistical method.
Table 4 Univariate and multivariate logistic regression models for
predictors of regional lymph node metastasis (results from 75th percentile
cutoffs)
Univariate analysis Multivariate analysis
a
Variables OR 95% CI P-value OR 95% CI P-value
CD3
b 0.375 0.194–0.726 0.004 0.425 0.204–0.885 0.022
CD8
b 0.436 0.225–0.843 0.014 0.325 0.150–0.707 0.005
CD45RO
b 0.420 0.217–0.815 0.010 0.402 0.190–0.850 0.017
CD3CD8
c 0.338 0.161–0.710 0.004 0.318 0.138–0.734 0.007
CD3CD45RO
c 0.321 0.149–0.689 0.004 0.337 0.143–0.793 0.013
CD8CD45RO
c 0.400 0.180–0.888 0.024 0.354 0.146–0.860 0.022
CD3CD8
CD45RO
d
0.369 0.160–0.851 0.019 0.397 0.160–0.988 0.047
CI¼confidence interval; OR¼odds ratio. The results were according to the density
groups of TIL with 75th percentile cutoffs. Univariate and multivariate logistic
regression models were used as statistical methods.
aTumour invasion (T stage) and
presence of lymphatic invasion were adopted as covariates in each multivariate
analysis.
bHigh vs low.
cHigh/high vs low/low.
dHigh/high/high vs low/low/low.
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seach stage (Figure 3). This finding suggests that the diversity of
clinical outcomes shown by gastric cancer patients with the same
TNM stage is due in part to differences in TIL density, which
underlines the importance of TIL as a predictor of clinical
outcome.
In this study, cases were classified into low or high TIL density
groups using mean number or 75th percentile cutoffs, and the
results were consistent regardless of the grouping method used. In
addition, analyses using two-fold cross-validation approach
strengthened our results, although it failed to show that CD3
þ
TIL density was an independent predictor of overall survival.
Nevertheless, the counting method using image analysis software
and the classification system used in this study would be difficult
to use clinically. Thus, we suggest that a standard method be
devised to measure TIL densities for clinical applications.
Recent studies on colorectal cancer have demonstrated that a
high density of CD45RO
þ TIL is correlated with the absence of
lymphovascular invasion and with increased survival (Pages et al,
2005), and further that the densities of CD3
þ, CD8
þ, and
CD45RO
þ TILs are independent prognostic factors (Galon et al,
2006). In a study on ovarian cancer, it was found that the presence
of intratumoral T cells was associated with improved clinical
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Figure 2 Kaplan–Meier survival plots for the 220 gastric cancer patients as a function of TIL density. (A) Significant differences in overall survival were
found between the low- and high-density groups of CD3, CD8, and CD45RO, by the log-rank tests. (B, C) Survival differences were consistently found
when analysing with diverse combined TIL variables (refer to Table 1).
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soutcome (Zhang et al, 2003). Previous reports also show that
hepatocellular and urothelial carcinoma patients with high
numbers of CD8
þ TIL within tumour tissues have better
survival (Gao et al, 2007; Sharma et al, 2007). In terms of
lymph node metastasis, Taylor et al (2007) reported that brisk
TIL infiltration in tumour predicts sentinel lymph node meta-
stasis in melanoma patients, and Piersma et al (2007) demon-
strated that a high number of intraepithelial CD8
þ TIL is
associated with the absence of lymph node metastasis in uterine
cervical cancer.
However, the prognostic role of tumour-infiltrating immune
cells in patients of gastric cancer is largely unknown. Only a few
reports have been issued on the association between tumour-
infiltrating immune cells and the clinical outcome in gastric
cancer; Ishigami et al (2000) reported that patients showing a high
level of natural killer cell infiltration in tumour tissues have a
better prognosis, and Maehara et al (1997) showed that a high
density of dendritic cell infiltration is associated with the absence
of lymph node metastasis. Ichihara et al (2003) reported that the
population of regulatory T cells among the TILs of patients with
advanced disease (n¼8) is significantly higher than that among
the TILs of patients with early disease (n¼7). On the other hand,
Fukuda et al (2002) found no significant difference in survival
between patients with marked or slight TIL infiltration, which does
not agree with our findings. However, they detected TILs by
UCLH-1 immunostaining in 129 gastric cancer patients, classified
cases into groups with marked or slight TIL infiltration, and
did not determine TIL numbers. In this study of a large series of
gastric cancers, we counted the number of tumour-infiltrating total
T cells, cytotoxic T cells, memory T cells, and B cells using an
image analyser, and for the first time demonstrated the prognostic
importance of TIL in gastric cancer.
T-cell mediated adaptive immunity is considered to play a major
role in anti-tumour immunity. In mouse models, it has been
demonstrated that adaptive immunity prevents the development of
tumours and inhibit tumour progression (Dunn et al, 2004).
Consistent with these results, our findings show that high densities
of immune cells related to adaptive immunity, that is, total T cells,
cytotoxic T cells, and memory T cells, are associated with
favourable survival, and indicate that adaptive immunity plays a
role in the prevention of tumour progression. On the other hand,
tumour-infiltrating B cells are found not to have impact on patient
survival in this study. Previous reports have concluded that B
lymphocytes and humoral immunity are associated with tumour
progression (de Visser et al, 2006; Sabbatini and Odunsi, 2007),
which is not contradicted by our findings.
According to our results, TIL density is correlated with the
presence of lymph node metastasis but not with depth of tumour
Table 5 Univariate and multivariate cox proportional hazards models for
the predictors of overall survival (results from mean value cutoffs)
Univariate analysis Multivariate analysis
a
Variables HR 95% CI P-value HR 95% CI P-value
CD3
b 0.627 0.410–0.627 0.031 0.813 0.523–1.264 0.358
CD8
b 0.583 0.358–0.950 0.030 0.574 0.347–0.949 0.031
CD45RO
b 0.530 0.331–0.850 0.008 0.612 0.377–0.995 0.048
CD3CD8
c 0.522 0.303–0.900 0.019 0.572 0.325–1.010 0.054
CD3CD45RO
c 0.441 0.252–0.772 0.004 0.565 0.317–1.009 0.054
CD8CD45RO
c 0.416 0.221–0.785 0.007 0.436 0.227–0.838 0.013
CD3CD8
CD45RO
d
0.393 0.202–0.766 0.006 0.471 0.236–0.937 0.032
CI¼confidence interval; HR¼hazard ratio. The results were according to the
density groups of TIL with mean value cutoffs. Univariate and multivariate Cox
proportional hazards models were used as statistical methods.
aTumour stage
(T stage), histologic classification (WHO), presence of lymph node metastasis, and
presence of lymphatic invasion which were proved to have a prognostic significance
in univariate analysis were adopted as covariates in each multivariate analysis.
bHigh vs
low.
cHigh/high vs low/low.
dHigh/high/high vs low/low/low.
Table 6 Univariate and multivariate cox proportional hazard models for
the predictors of overall survival (results from 75th percentile cutoffs)
Univariate analysis Multivariate analysis
a
Variables HR 95% CI P-value HR 95% CI P-value
CD3
b 0.446 0.261–0.760 0.003 0.549 0.317–0.951 0.032
CD8
b 0.583 0.358–0.950 0.030 0.574 0.347–0.949 0.031
CD45RO
b 0.483 0.287–0.813 0.006 0.507 0.298–0.862 0.012
CD3CD8
c 0.373 0.193–0.721 0.003 0.403 0.205–0.795 0.009
CD3CD45RO
c 0.305 0.147–0.632 0.001 0.337 0.161–0.708 0.004
CD8CD45RO
c 0.418 0.216–0.809 0.010 0.413 0.211–0.812 0.010
CD3CD8
CD45RO
d
0.271 0.118–0.624 0.002 0.282 0.121–0.658 0.003
CI¼confidence interval; HR¼hazard ratio. The results were according to the
density groups of TIL with 75th percentile cutoffs. Univariate and multivariate
Cox proportional hazards models were used as statistical methods.
aTumour stage
(T stage), histologic classification (WHO), presence of lymph node metastasis, and
presence of lymphatic invasion which were proved to have prognostic significance in
univariate analysis were adopted as covariates in each multivariate analysis.
bHigh vs
low.
cHigh/high vs low/low.
dHigh/high/high vs low/low/low.
Table 7 Univariate and multivariate logistic regression models for
predictors of regional lymph node metastasis (results from two-fold cross-
validation approach)
Univariate analysis Multivariate analysis
a
Variables OR 95% CI P-value OR 95% CI P-value
CD3
b 0.42 0.211–0.818 0.011 0.45 0.213–0.935 0.033
CD8
b 0.32 0.158–0.630 0.001 0.34 0.162–0.723 0.005
CD45RO
b 0.29 0.153–0.554 o0.001 0.27 0.128–0.554 o0.001
CD3CD8
c 0.28 0.124–0.614 0.001 0.31 0.128–0.729 0.003
CD3CD45RO
c 0.26 0.123–0.527 o0.001 0.25 0.108–0.563 o0.001
CD8CD45RO
c 0.21 0.097–0.459 0.001 0.20 0.085–0.479 0.001
CD3CD8
CD45RO
d
0.20 0.083–0.463 o0.001 0.20 0.077–0.518 o0.001
CI¼confidence interval; OR¼odds ratio. Univariate and multivariate logistic
regression models were used as statistical methods.
aTumour invasion (T stage)
and presence of lymphatic invasion were adopted as covariates in each multivariate
analysis.
bhigh vs low.
chigh/high vs low/low.
dhigh/high/high vs low/low/low.
Table 8 Univariate and multivariate cox proportional hazards models for
the predictors of overall survival (results from two-fold cross-validation
approach)
Univariate analysis Multivariate analysis
a
Variables HR 95% CI P-value HR 95% CI P-value
CD3
b 0.57 0.343–0.935 0.026 0.67 0.404–1.123 0.130
CD8
b 0.59 0.374–0.938 0.026 0.64 0.408–1.003 0.052
CD45RO
b 0.30 0.151–0.594 0.001 0.42 0.209–0.843 0.015
CD3CD8
c 0.49 0.288–0.837 0.009 0.56 0.324–0.964 0.037
CD3CD45RO
c 0.34 0.162–0.691 0.003 0.44 0.211–0.923 0.030
CD8CD45RO
c 0.28 0.134–0.592 0.001 0.36 0.170–0.768 0.008
CD3CD8
CD45RO
d
0.31 0.148–0.656 0.002 0.39 0.185–0.836 0.015
CI¼confidence interval; HR¼hazard ratio. Univariate and multivariate Cox
proportional hazard models were used as statistical methods.
aTumour stage
(T stage), histologic classification (WHO), presence of lymph node metastasis, and
presence of lymphatic invasion which were proved to have prognostic significance
in univariate analysis were adopted as covariates in each multivariate analysis.
bhigh vs
low.
chigh/high vs low/low.
dhigh/high/high vs low/low/low.
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sinvasion. On the basis of this finding, we suspect that the
prognostic role of TIL is mainly contributed to decreased
metastatic potential. We suggest the following possible mechan-
isms how TIL act to reduce metastatic potential. First, clones with
metastatic potential usually contain larger amounts of aberrantly
expressed proteins, including proteins that contribute to metas-
tasis, which may act as tumour-associated antigens. As a result,
these clones are more likely to be destroyed by in situ immune
reactions. Second, a high density of TIL means a healthy immune
system, and therefore, immune reaction occurring in lymph node
may also exert a proper function against tumour cells that have
drained into lymph nodes in patients with high TIL densities.
Third, tumour burden of metastatic foci in lymph node is less
bulky than those of primary foci, and thus, metastatic foci are
more likely to be susceptible to complete destruction by immune
reaction.
In this study, we evaluated TIL distributions immunohisto-
chemically, and although the majority of previous reports have
also used this method, it has some limitations. First, the results
obtained are dependent on the antibodies used. Second, various
components of immune system such as interferon-g (IFN-g), IFN-g
receptor, transcription factor signal transducers and activators of
transcription 1 (STAT1), perforin, and interleukins which can
affect in situ immune reaction against tumour, and therefore,
impact on patients’ survival were not considered. Thus, additional
studies are required to elucidate the expressional status of
immune-related genes in tumour tissues.
Significant advances have been made in the field of cancer
immunotherapy over the last decade, and many nonrandomised,
phase II, immune-targeted trials have shown that immunotherapy
can confer survival benefits, although these benefits were not
confirmed in phase III trials (Rosenberg et al, 2004; Sabbatini and
Odunsi, 2007). In gastric cancer, immunotherapy has not been
shown to confer a survival benefit, although a clinical trial on
postoperative adjuvant immunochemotherapy is currently in
progress in Japan (Ueda et al, 2006). It is hoped that the
observations made during this study will provide crucial informa-
tion concerning the design of effective immunotherapies, and aid
the identification of patients suitable for immunotherapy.
In conclusion, we elucidated the prognostic implications of the
density of various types of TIL in gastric cancer. Moreover, our
results suggest that adaptive immunity does act to prevent tumour
progression. We believe that our findings can help predict clinical
outcome and define patient subgroups with an unfavourable
prognosis in gastric cancer. Furthermore, our observation will be
useful for selecting patients that are more likely to benefit from the
promising adjuvant immunotherapy.
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